Blundell Biotech. Blundell Biotech is a U.S.-based biotechnology company with operations and earnings in a number of foreign countries. The company's profits by subsidiary, in local currency (in millions), are shown in the table

(a)

Japanese

Subsidiary

British

Subsidiary

European

Subsidiary

Chinese

Subsidiary

Russian

Subsidiary

United States

Subsidiary

Net Income

JPY

GBP

EUR

CNY

RUB

USD

2013

1491

104.71

212.33

173.43

128.41

350.62

2014

1452

105.45

216.76

195.34

117.95

374.92

(b)

Exchange Rate

JPY = 1 USD

USD = 1 GBP

USD = 1 EUR

CNY = 1 USD

RUB = 1 USD

USD

2013

97.55

1.5157

1.3313

6.2141

31.89

1

2014

105.84

1.639

1.3803

6.2148

38.67

1

for 2013 and 2014.

a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014?

b. If the same exchange rates were used for both years, what was the change in corporate earnings on a "constant currency" basis?

c. Using the results of the constant currency analysis in part

(b),

is it possible to separate Blundell's growth in earnings between local currency earnings and foreign exchange rate impacts on a consolidated basis?

a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014?

Consolidated profits or earnings is found by consolidating the converted profits in each foreign currency to U.S. dollars for that period. (This is simplified. Actual accounting practices would require the additional netting of any intra-company transactions resulting to eliminate any double-counting of profits.)

Calculate the consolidated profits in U.S. dollars in 2013 and 2014 below: (Round to two decimal places)

Net Income

Japanese

(USD)

Subsidiary

(2013)

(2014)

Change (%)